Pediatric Toxicology

Emergency Medicine Clinics of North America

Volumn 25, Issue 2, 2007, Pages 283-308

  Eldridge, David L ^a   Van Eyk, Jason ^a   Kornegay, Chad ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CARBON; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIMALARIAL AGENT; ATROPINE PLUS DIPHENOXYLATE; BENZOCAINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAMPHOR; CLONIDINE; COSMETIC; DIPHENHYDRAMINE; DOMESTIC CHEMICAL; HYDROXYCHLOROQUINE; IPECAC; LAXATIVE; LINDANE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SALICYLIC ACID; SULFONYLUREA; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AGITATION; ANXIETY; APNEA; APPETITE; ASPIRATION; BEHAVIOR; BLOATING; BRADYCARDIA; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DEPRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CHILD HEALTH CARE; CHILDHOOD MORTALITY; CLUBBING FINGERS; COMA; CONSTIPATION; CONVULSION; DEFECATION DISORDER; DIARRHEA; DIZZINESS; DROWSINESS; DRUG FATALITY; DRUG INTOXICATION; DRY SKIN; DYSPNEA; ELECTROCARDIOGRAPHY; FATIGUE; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERREFLEXIA; HYPERTHERMIA; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; INTESTINE SOUND; INTOXICATION; IRRITABILITY; LABORATORY TEST; LETHARGY; LUNG DISEASE; LUNG EDEMA; MALARIA; MENTAL HEALTH; METABOLIC ACIDOSIS; MIOSIS; MUCOSA; MUCOSAL DISEASE; MUSCLE HYPOTONIA; MUSCLE STIFFNESS; MUSCLE WEAKNESS; MYALGIA; MYDRIASIS; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY ALKALOSIS; RESPIRATORY FAILURE; REVIEW; SEIZURE; SHOCK; SIDE EFFECT; SYNCOPE; TACHYCARDIA; TACHYPNEA; TENDON REFLEX; THORAX PAIN; TINNITUS; TREMOR; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VOMITING; WEAKNESS; WEIGHT REDUCTION; XEROSTOMIA;

EID: 34247552826     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2007.02.011     Document Type: Review

References (121)

1. Watson W.A., Litovitz T.L., Rodgers Jr. G.C., et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23 5 (2005) 589-666
2. Crouch B.I., Caravati E.M., and Booth J. Trends in child and teen nonprescription drug abuse reported to a regional poison control center. Am J Health Syst Pharm 61 12 (2004) 1252-1257
3. Veltri J.C., and Litovitz T.L. 1983 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 2 5 (1984) 420-443
4. Litovitz T., and Veltri J.C. 1984 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 3 5 (1985) 423-450
5. Litovitz T.L., Normann S.A., and Veltri J.C. 1985 Annual Report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 4 5 (1986) 427-458
6. Litovitz T.L., Martin T.G., and Schmitz B. 1986 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 5 5 (1987) 405-445
7. Litovitz T.L., Schmitz B.F., Matyunas N., et al. 1987 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 6 5 (1988) 479-515
8. Litovitz T.L., Schmitz B.F., and Holm K.C. 1988 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 7 5 (1989) 495-545
9. Litovitz T.L., Schmitz B.F., and Bailey K.M. 1989 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 8 5 (1990) 394-442
10. Litovitz T.L., Bailey K.M., Schmitz B.F., et al. 1990 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 9 5 (1991) 461-509
11. Litovitz T.L., Holm K.C., Bailey K.M., et al. 1991 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 10 5 (1992) 452-505
12. Litovitz T.L., Holm K.C., Clancy C., et al. 1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 11 5 (1993) 494-555
13. Litovitz T.L., Clark L.R., and Soloway R.A. 1993 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 12 5 (1994) 546-584
14. Litovitz T.L., Felberg L., Soloway R.A., et al. 1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 13 5 (1995) 551-597
15. Litovitz T.L., Felberg L., White S., et al. 1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 14 5 (1996) 487-537
16. Litovitz T.L., Smilkstein M., Felberg L., et al. 1996 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 15 5 (1997) 447-500
17. Litovitz T.L., Klein-Schwartz W., Dyer K.S., et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 16 5 (1998) 443-497
18. Litovitz T.L., Klein-Schwartz W., Caravati E.M., et al. 1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 17 5 (1999) 435-487
19. Litovitz T.L., Klein-Schwartz W., White S., et al. 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 18 5 (2000) 517-574
20. Litovitz T.L., Klein-Schwartz W., White S., et al. 2000 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 19 5 (2001) 337-395
21. Litovitz T.L., Klein-Schwartz W., Rodgers Jr. G.C., et al. 2001 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20 5 (2002) 391-452
22. Watson W.A., Litovitz T.L., Rodgers Jr. G.C., et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21 5 (2003) 353-421
23. Watson W.A., Litovitz T.L., Klein-Schwartz W., et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22 5 (2004) 335-404
24. Muller A.A. Small amounts of some drugs can be toxic to young children: one pill or one swallow can require aggressive treatment. J Emerg Nurs 29 3 (2003) 290-293
25. Bar-Oz B., Levichek Z., and Koren G. Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update. Paediatr Drugs 6 2 (2004) 123-126
26. Michael J.B., and Sztajnkrycer M.D. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin North Am 22 4 (2004) 1019-1050
27. Henry K., and Harris C.R. Deadly ingestions. Pediatr Clin North Am 53 2 (2006) 293-315
28. Kerr G.W., McGuffie A.C., and Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J 18 4 (2001) 236-241
29. Rosenbaum T.G., and Kou M. Are one or two dangerous? Tricyclic antidepressant exposure in toddlers. J Emerg Med 28 2 (2005) 169-174
30. McFee R.B., Mofenson H.C., and Caraccio T.R. A nationwide survey of the management of unintentional low-dose tricyclic antidepressant ingestions involving asymptomatic children: implications for the development of an evidence-based clinical guideline. J Toxicol Clin Toxicol 38 1 (2000) 15-19
31. McFee R.B., Caraccio T.R., and Mofenson H.C. Selected tricyclic antidepressant ingestions involving children 6 years old or less. Acad Emerg Med 8 2 (2001) 139-144
32. Smith E.R., and Klein-Schwartz W. Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers. J Emerg Med 28 4 (2005) 437-443
33. Matteucci M.J. One pill can kill: assessing the potential for fatal poisonings in children. Pediatr Ann 34 12 (2005) 964-968
34. Jordan P., Brookes J.G., Nikolic G., et al. Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol Clin Toxicol 37 7 (1999) 861-864
35. DeWitt C.R., and Waksman J.C. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 23 4 (2004) 223-238
36. Vaghy P.L., Williams J.S., and Schwartz A. Receptor pharmacology of calcium entry blocking agents. Am J Cardiol 59 2 (1987) 9A-17A
37. Belson M.G., Gorman S.E., Sullivan K., et al. Calcium channel blocker ingestions in children. Am J Emerg Med 18 5 (2000) 581-586
38. Lee D.C., Greene T., Dougherty T., et al. Fatal nifedipine ingestions in children. J Emerg Med 19 4 (2000) 359-361
39. Love J.N., Sammon M., and Smereck J. Are one or two dangerous? Camphor exposure in toddlers. J Emerg Med 27 1 (2004) 49-54
40. Phelan III W.J. Camphor poisoning: over-the-counter dangers. Pediatrics 57 3 (1976) 428-431
41. Ratnapalan S., Potylitsina Y., Tan L.H., et al. Measuring a toddler's mouthful: toxicologic considerations. J Pediatr 142 6 (2003) 729-730
42. Sachdeva D.K., and Stadnyk J.M. Are one or two dangerous? Opioid exposure in toddlers. J Emerg Med 29 1 (2005) 77-84
43. Aronow R., Paul S.D., and Woolley P.V. Childhood poisoning. An unfortunate consequence of methadone availability. JAMA 219 3 (1972) 321-324
44. von Muhlendahl K.E., Scherf-Rahne B., Krienke E.G., et al. Codeine intoxication in childhood. Lancet 2 7980 (1976) 303-305
45. Bosse G.M., and Matyunas N.J. Delayed toxidromes. J Emerg Med 17 4 (1999) 679-690
46. Little G.L., and Boniface K.S. Are one or two dangerous? Sulfonylurea exposure in toddlers. J Emerg Med 28 3 (2005) 305-310
47. Quadrani D.A., Spiller H.A., and Widder P. Five-year retrospective evaluation of sulfonylurea ingestion in children. J Toxicol Clin Toxicol 34 3 (1996) 267-270
48. Spiller H.A., Villalobos D., Krenzelok E.P., et al. Prospective multicenter study of sulfonylurea ingestion in children. J Pediatr 131 1 Pt 1 (1997) 141-146
49. Borowski H., Caraccio T., and Mofenson H. Sulfonylurea ingestion in children: is an 8-hour observation period sufficient?. J Pediatr 133 4 (1998) 584-585
50. Rumack B.H., and Temple A.R. Lomotil poisoning. Pediatrics 53 4 (1974) 495-500
51. McCarron M.M., Challoner K.R., and Thompson G.A. Diphenoxylate-atropine (Lomotil) overdose in children: an update (report of eight cases and review of the literature). Pediatrics 87 5 (1991) 694-700
52. Wasserman G.S., Green V.A., and Wise G.W. Lomotil ingestions in children. Am Fam Physician 11 6 (1975) 93-97
53. Penfold D., and Volans G.N. Overdose from Lomotil. Br Med J 2 6099 (1977) 1401-1402
54. Silber T.J. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?. J Adolesc Health 37 3 (2005) 256-260
55. Wald A. Is chronic use of stimulant laxatives harmful to the colon?. J Clin Gastroenterol 36 5 (2003) 386-389
56. Turner J., Batik M., Palmer L.J., et al. Detection and importance of laxative use in adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 39 3 (2000) 378-385
57. Schreier H. Munchausen by proxy defined. Pediatrics 110 5 (2002) 985-988
58. Shannon M. The demise of ipecac. Pediatrics 112 5 (2003) 1180-1181
59. Krassner L. TIPP usage. Pediatrics 74 5 Pt 2 (1984) 976-980
60. Vale J.A., Meredith T.J., and Proudfoot A.T. Syrup of ipecacuanha: is it really useful?. Br Med J (Clin Res Ed) 293 6558 (1986) 1321-1322
61. Litovitz T. In defense of retaining ipecac syrup as an over-the-counter drug. Pediatrics 82 3 Pt 2 (1988) 514-516
62. Poison treatment in the home. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention. Pediatrics 112 5 (2003) 1182-1185
63. Position paper: ipecac syrup. J Toxicol Clin Toxicol 42 2 (2004) 133-143
64. Ente G., and Penzer P.H. New abuse of ipecac. Pediatrics 77 1 (1986) 134-135
65. Cooper C., Kilham H., and Ryan M. Ipecac-a substance of abuse. Med J Aust 168 2 (1998) 94-95
66. Vanin J.R. Ipecac abuse-danger. J Am Coll Health 40 5 (1992) 237-238
67. Greenfeld D., Mickley D., Quinlan D.M., et al. Ipecac abuse in a sample of eating disordered outpatients. Int J Eat Disord 13 4 (1993) 411-414
68. Dawson J.A., and Yager J. A case of abuse of syrup of ipecac resulting in death. J Am Coll Health 34 6 (1986) 280-282
69. Schiff R.J., Wurzel C.L., Brunson S.C., et al. Death due to chronic syrup of ipecac use in a patient with bulimia. Pediatrics 78 3 (1986) 412-416
70. Adler A.G., Walinsky P., Krall R.A., et al. Death resulting from ipecac syrup poisoning. JAMA 243 19 (1980) 1927-1928
71. Friedman E.J. Death from ipecac intoxication in a patient with anorexia nervosa. Am J Psychiatry 141 5 (1984) 702-703
72. Pope Jr. H.G., Hudson J.I., Nixon R.A., et al. The epidemiology of ipecac abuse. N Engl J Med 314 4 (1986) 245-246
73. Andersen J.M., Keljo D.J., and Argyle J.C. Secretory diarrhea caused by ipecac poisoning. J Pediatr Gastroenterol Nutr 24 5 (1997) 612-615
74. Bader A.A., and Kerzner B. Ipecac toxicity in Munchausen syndrome by proxy. Ther Drug Monit 21 2 (1999) 259-260
75. Cooper C.P., and Kamath K.R. A toddler with persistent vomiting and diarrhoea. Eur J Pediatr 157 9 (1998) 775-776
76. Goebel J., Gremse D.A., and Artman M. Cardiomyopathy from ipecac administration in Munchausen syndrome by proxy. Pediatrics 92 4 (1993) 601-603
77. McClung H.J., Murray R., Braden N.J., et al. Intentional ipecac poisoning in children. Am J Dis Child 142 6 (1988) 637-639
78. Santangelo W.C., Richey J.E., Rivera L., et al. Surreptitious ipecac administration simulating intestinal pseudo-obstruction. Ann Intern Med 110 12 (1989) 1031-1032
79. Schneider D.J., Perez A., Knilamus T.E., et al. Clinical and pathologic aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy. Pediatrics 97 6 Pt 1 (1996) 902-906
80. Sutphen J.L., and Saulsbury F.T. Intentional ipecac poisoning: Munchausen syndrome by proxy. Pediatrics 82 3 Pt 2 (1988) 453-456
81. Manno B.R., and Manno J.E. Toxicology of ipecac: a review. Clin Toxicol 10 2 (1977) 221-242
82. Dresser L.P., Massey E.W., Johnson E.E., et al. Ipecac myopathy and cardiomyopathy. J Neurol Neurosurg Psychiatry 56 5 (1993) 560-562
83. Carraccio C., Blotny K., and Ringel R. Sudden onset of profound weakness in a toddler. J Pediatr 122 4 (1993) 663-667
84. Halbig L., Gutmann L., Goebel H.H., et al. Ultrastructural pathology in emetine-induced myopathy. Acta Neuropathol (Berl) 75 6 (1988) 577-582
85. Mateer J.E., Farrell B.J., Chou S.S., et al. Reversible ipecac myopathy. Arch Neurol 42 2 (1985) 188-190
86. Rashid N. Medically unexplained myopathy due to ipecac abuse. Psychosomatics 47 2 (2006) 167-169
87. Palmer E.P., and Guay A.T. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med 313 23 (1985) 1457-1459
88. Ho P.C., Dweik R., and Cohen M.C. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin Cardiol 21 10 (1998) 780-783
89. Yamashita M., Yamashita M., and Azuma J. Urinary excretion of ipecac alkaloids in human volunteers. Vet Hum Toxicol 44 5 (2002) 257-259
90. Mitchell J.E., Boutacoff L.I., Hatsukami D., et al. Laxative abuse as a variant of bulimia. J Nerv Ment Dis 174 3 (1986) 174-176
91. Kiningham R.B., and Gorenflo D.W. Weight loss methods of high school wrestlers. Med Sci Sports Exerc 33 5 (2001) 810-813
92. Ackerman Jr. N.B., and Strobel C.T. Polle syndrome: chronic diarrhea in Munchausen's child. Gastroenterology 81 6 (1981) 1140-1142
93. Epstein M.A., Markowitz R.L., Gallo D.M., et al. Munchausen syndrome by proxy: considerations in diagnosis and confirmation by video surveillance. Pediatrics 80 2 (1987) 220-224
94. Volk D. Factitious diarrhea in two children. Am J Dis Child 136 11 (1982) 10127-10128
95. Thompson W.G. Laxatives: clinical pharmacology and rational use. Drugs 19 1 (1980) 49-58
96. Xing J.H., and Soffer E.E. Adverse effects of laxatives. Dis Colon Rectum 44 8 (2001) 1201-1209
97. Baker E.H., and Sandle G.I. Complications of laxative abuse. Annu Rev Med 47 (1996) 127-134
98. Oster J.R., Materson B.J., and Rogers A.I. Laxative abuse syndrome. Am J Gastroenterol 74 5 (1980) 451-458
99. Vanin J.R., and Saylor K.E. Laxative abuse: a hazardous habit for weight control. J Am Coll Health 37 5 (1989) 227-230
100. Malmquist J., Ericsson B., Hulten-Nosslin M.B., et al. Finger clubbing and aspartylglucosamine excretion in a laxative-abusing patient. Postgrad Med J 56 662 (1980) 862-864
101. Pines A., Olchovsky D., Bregman J., et al. Finger clubbing associated with laxative abuse. South Med J 76 8 (1983) 1071-1072
102. Prior J., and White I. Tetany and clubbing in patient who ingested large quantities of senna. Lancet 2 8096 (1978) 947
103. Silk D.B., Gibson J.A., and Murray C.R. Reversible finger clubbing in a case of purgative abuse. Gastroenterology 68 4 Pt 1 (1975) 790-794
104. Stolk L.M., and Hoogtanders K. Detection of laxative abuse by urine analysis with HPLC and diode array detection. Pharm World Sci 21 1 (1999) 40-43
105. Muller-Lissner S. What has happened to the cathartic colon?. Gut 39 3 (1996) 486-488
106. Wald A. Constipation in the primary care setting: current concepts and misconceptions. Am J Med 119 9 (2006) 736-739
107. Spiller H.A., and Rodgers Jr. G.C. Evaluation of administration of activated charcoal in the home. Pediatrics 108 6 (2001) E100
108. Burns M.M. Activated charcoal as the sole intervention for treatment after childhood poisoning. Curr Opin Pediatr 12 2 (2000) 166-171
109. Tenenbein M. Gastrointestinal decontamination of the overdose patient in the year 2000. Clinical Pediatric Emergency Medicine 1 3 (2000) 195-199
110. Chyka P.A., Seger D., Krenzelok E.P., et al. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 43 2 (2005) 61-87
111. Dockstader L.L., Lawrence R.A., and Bresnick H.L. Home administration of activated charcoal: feasibility and acceptance. Vet Hum Toxicol 28 5 (1986) 471
112. Grbcich P.A., Lacouture P.G., and Woolf A. Administration of charcoal in the home. Vet Hum Toxicol 29 6 (1987) 458
113. Lamminpaa A., Vilska J., and Hoppu K. Medical charcoal for a child's poisoning at home: availability and success of administration in Finland. Hum Exp Toxicol 12 1 (1993) 29-32
114. Dilger I., Brockstedt M., Oberdisse U., et al. Activated charcoal is needed rarely in children but can be administered safely by the lay public. J Toxicol Clin Toxicol 37 (1999) 402-403
115. Scharman E.J., Cloonan H.A., and Durback-Morris L.F. Home administration of charcoal: can mothers administer a therapeutic dose?. J Emerg Med 21 4 (2001) 357-361
116. Osterhoudt K.C., Alpern E.R., Durbin D., et al. Activated charcoal administration in a pediatric emergency department. Pediatr Emerg Care 20 8 (2004) 493-498
117. Spiller H.A. Home administration of charcoal. J Emerg Med 25 1 (2003) 106-107 [author reply: 107]
118. Graff G.R., Stark J., Berkenbosch J.W., et al. Chronic lung disease after activated charcoal aspiration. Pediatrics 109 5 (2002) 959-961
119. Justiniani F.R., Hippalgaonkar R., and Martinez L.O. Charcoal-containing empyema complicating treatment for overdose. Chest 87 3 (1985) 404-405
120. Elliott C.G., Colby T.V., Kelly T.M., et al. Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 96 3 (1989) 672-674
121. Menzies D.G., Busuttil A., and Prescott L.F. Fatal pulmonary aspiration of oral activated charcoal. BMJ 297 6646 (1988) 459-460